Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to demonstrate the efficacy and safety of aripiprazole in
children and adolescents aged 6~18 years with chronic tic disorders or Tourette's disorder